Protagonist Therapeutics, Inc. (NASDAQ:PTGX) Given Average Rating of “Buy” by Brokerages
Shares of Protagonist Therapeutics, Inc. (NASDAQ:PTGX – Get Free Report) have been assigned an average recommendation of “Buy” from the six brokerages that are currently covering the stock, MarketBeat Ratings reports. Six research analysts have rated the stock with a buy recommendation. The average 1-year price target among analysts that have updated their coverage on […]
More Stories
Trump Says US Negotiators Will Travel to Pakistan for Peace Talks With Iran
By Tom Gantert President Donald Trump said on Sunday that U.S. representatives will arrive in Pakistan on Monday evening in...
Six Dead After Shooter Opens Fire in Kyiv
By Jacki Thrapp At least six people died on April 18 when a man opened fire in Kyiv’s Holosiivskyi district....
USDA Disqualifies 1,562 Retailers, Prevents $835 Million in Fraudulent SNAP Transactions
By Naveen Athrappully The U.S. Department of Agriculture’s Food and Nutrition Service has disqualified 1,562 retailers associated with the Supplemental...
Abbott Threatens $200 Million in Funding Cuts Across Texas’s Largest Cities Over ICE Policies
By Kimberly Hayek Texas Gov. Greg Abbott on April 16 threatened to cut more than $200 million in public safety...
Wall Street Review: S&P 500 Surpasses 7,100 for First Time
By Panos Mourdoukoutas Stocks extended their rebound into the third week of April, with the S&P 500 and Nasdaq reaching...
Appeals Court Allows Construction of White House Ballroom to Continue
By Aldgra Fredly A U.S. appeals court on April 17 put on hold a lower court order that had halted...